[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Peripheral Arterial Disease (PAD) Drugs Market Status and Outlook 2018-2025

July 2018 | 140 pages | ID: G8662511485EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • AstraZeneca Plc. (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bristol-Myers Squibb Company (US)
  • Merck & Co., Inc. (US)
  • Proteon Therapeutics, Inc. (US)
  • Sanofi S.A. (France)
  • Symic Bio, Inc. (US)
  • TheraVasc Inc. (US)
Market by Type
  • Clopidogrel (Plavix)
  • Prasugrel (Effient)
  • Ticagrelor (Brilinta)
  • Vorapaxar (Zontivity)
  • Others
Market by Application
  • Hospitals
  • Clinics
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Peripheral Arterial Disease (PAD) Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Clopidogrel (Plavix)
  3.1.2 Prasugrel (Effient)
  3.1.3 Ticagrelor (Brilinta)
  3.1.4 Vorapaxar (Zontivity)
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Clinics
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Clopidogrel (Plavix) Production by Region
    6.1.1.2 Prasugrel (Effient) Production by Region
    6.1.1.3 Ticagrelor (Brilinta) Production by Region
    6.1.1.4 Vorapaxar (Zontivity) Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Clinics Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Clopidogrel (Plavix) Demand by Region
    6.2.1.2 Prasugrel (Effient) Demand by Region
    6.2.1.3 Ticagrelor (Brilinta) Demand by Region
    6.2.1.4 Vorapaxar (Zontivity) Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Clinics Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 AstraZeneca Plc. (UK)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Bayer HealthCare Pharmaceuticals (Germany)
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Bristol-Myers Squibb Company (US)
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Merck & Co., Inc. (US)
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Proteon Therapeutics, Inc. (US)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Sanofi S.A. (France)
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Symic Bio, Inc. (US)
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 TheraVasc Inc. (US)
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Peripheral Arterial Disease (PAD) Drugs Industry Dynamics & Regulations List
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Peripheral Arterial Disease (PAD) Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Status by Application 2015-2018E, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Region 2015-2018E, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2018, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Region 2015-2018E, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2018, in Volume
Table Clopidogrel (Plavix) Production Value by Region 2015-2018E, in USD Million
Table Clopidogrel (Plavix) Production Volume by Region 2015-2018E, in Volume
Table Prasugrel (Effient) Production Value by Region 2015-2018E, in USD Million
Table Prasugrel (Effient) Production Volume by Region 2015-2018E, in Volume
Table Ticagrelor (Brilinta) Production Value by Region 2015-2018E, in USD Million
Table Ticagrelor (Brilinta) Production Volume by Region 2015-2018E, in Volume
Table Vorapaxar (Zontivity) Production Value by Region 2015-2018E, in USD Million
Table Vorapaxar (Zontivity) Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Clinics Production Value by Region 2015-2018E, in USD Million
Table Clinics Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Clopidogrel (Plavix) Market Size by Region 2015-2018E, in USD Million
Table Clopidogrel (Plavix) Market Size by Region 2015-2018E, in Volume
Table Prasugrel (Effient) Market Size by Region 2015-2018E, in USD Million
Table Prasugrel (Effient) Market Size by Region 2015-2018E, in Volume
Table Ticagrelor (Brilinta) Market Size by Region 2015-2018E, in USD Million
Table Ticagrelor (Brilinta) Market Size by Region 2015-2018E, in Volume
Table Vorapaxar (Zontivity) Market Size by Region 2015-2018E, in USD Million
Table Vorapaxar (Zontivity) Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Clinics Market Size by Region 2015-2018E, in USD Million
Table Clinics Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalPeripheral Arterial Disease (PAD) Drugs Forecast by Type 2019F-2025F, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Forecast by Type 2019F-2025F, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast by Region 2019F-2025F, in Volume
Table AstraZeneca Plc. (UK) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of AstraZeneca Plc. (UK)
Table Bayer HealthCare Pharmaceuticals (Germany) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Bayer HealthCare Pharmaceuticals (Germany)
Table Bristol-Myers Squibb Company (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Bristol-Myers Squibb Company (US)
Table Merck & Co., Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Merck & Co., Inc. (US)
Table Proteon Therapeutics, Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Proteon Therapeutics, Inc. (US)
Table Sanofi S.A. (France) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Sanofi S.A. (France)
Table Symic Bio, Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Symic Bio, Inc. (US)
Table TheraVasc Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of TheraVasc Inc. (US)
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Peripheral Arterial Disease (PAD) Drugs Picture
Figure Peripheral Arterial Disease (PAD) Drugs Industry Chain Diagram
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Volume 2015-2018E, in Volume
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Price Forecast 2019F-2025F
Figure Global Peripheral Arterial Disease (PAD) Drugs Gross Margin Forecast 2019F-2025F
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Price by Company in 2018
Figure Global Peripheral Arterial Disease (PAD) Drugs Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories